x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Axiom Catalyst

Axiom Healthcare Strategies

Axiom Catalyst is your go-to for Life Sciences updates, news, and discussion. We will also feature guest speakers to comment on newsworthy developments. Powered by Axiom Healthcare Strategies, and hosted by Hafiz Sikder and the Think Tank Table.

science life sciences

All Episodes

00:21:26

Rare Neurological Diseases: Frédéric Destrebecq on...

Axiom Catalyst ·

2023/04/19

There are~ 30 million people in Europe alone living with a rare condition, of which 75% have neurological symptoms. While significant progress has been made to address needs of these patients, key challenges remain including the scarcity of the expertise and fragmentation of research efforts that translate into delayed diagnosis, few disease modifying therapies, and difficulty in accessing adequate care. In this episode of Axiom Catalyst, we invited Frédéric Destrebecq, the Executive Director of the

en-us

00:31:11

Sickle Cell Disease: John James sharing patient...

Axiom Catalyst ·

2023/04/11

While significant therapeutic advances are underway for inherited blood disorders such as sickle cell disease, hemophilia and β-thalassemia, key challenges remain for the commercialization of these therapies, as well as disparities in access to these treatments and level of care received by patients. In this episode of Axiom Catalyst, we invited John James, CEO of Sickle Cell Society to discuss the impact of sickle celldisease on day-to-day lives of patients living in the UK, as well as current

en-us

00:27:30

Post ASCO GU 2023

Axiom Catalyst ·

2023/02/28

Join Nicole, Kiana, and Madelyn's discussion on updates seen at ASCO GU 2023. We analyze some of the most anticipated read outs in RCC, bladder, and prostate cancers and consider what this data means for physicians and patients.

en-us

00:24:42

Bispecifics vs. CAR-Ts in Heme Cancers

Axiom Catalyst ·

2023/02/11

Join Justin, Rodrigo and Eriko’s discussion on bispecific antibody and CAR-T therapies. These innovative options are increasingly becoming available in late-line treatments for heme cancers. In this episode, we cover the advantages and disadvantages of bispecific and CAR-T treatments, emerging CRS considerations, as well as future directions for both modalities in how they pertain to myeloma and lymphoma treatment.

en-us

00:16:28

Post ASCO GI 2023

Axiom Catalyst ·

2023/02/01

Join Mahim, Samy, & Aman on exciting updates following the ASCO Gastrointestinal Cancers Symposium data readouts as we start 2023 with some exciting updates. In this episode, we share the latest news following recent approvals, 3-year data readouts, and developments in Gastrointestinal, Pancreatic, Colorectal, Hepatocellular Carcinoma, and Biliary Tract Cancer.

en-us

00:12:10

The Latest in Gynecologic Oncology

Axiom Catalyst ·

2023/01/09

Join Mahim and Allegra's discussions on the latest developments in gynecologic oncology as we wrap up 2022 and enter into the new year. In this episode, we recap the impact of antibody drug-conjugate approvals in cervical and ovarian cancers, new PARP inhibitor data in ovarian cancer, and exciting immunotherapy results in frontline endometrial cancer.

en-us

00:16:18

Gamma Delta Inspired Therapies with Anne Cherry

Axiom Catalyst ·

2022/11/23

In collaboration with Nick Gherardin from University of Melbourne, and Hafiz, Anne has recently co-authored a review article in Frontiers in Oncology about the novel clinical strategies companies are taking to bring gamma delta-inspired therapies to the clinic. Anne Cherry joins the Axiom Catalyst with Mahim Misra to discuss her paper and some of the exciting developments in gamma delta inspired therapies.

en-us

00:22:22

Dr. John Tsai on Leadership and the Future of BioPharma

Axiom Catalyst ·

2022/11/18

Dr. John Tsai, former President of Global Drug Development and CMO of Novartis, joins the Axiom Table with Hafiz Sikder. The conversation spans the changing landscape of Immuno-Oncology, AI, and the impact of COVID-19.

en-us

00:13:37

tRNA, Innovation, and Disruption with Michelle Werner

Axiom Catalyst ·

2022/09/28

Michelle Werner, CEO Partner of Flagship Pioneering and CEO of Alltrna, joins Hafiz Sikder to discuss her work and role at Alltrna as well as her personal investment in the field. She dives deep into the impact of tRNA on drug development, premature stop codons, and her drive to do more for rare disease.

en-us

00:12:22

Live From the Congress floor, ESMO 2022: RCC

Axiom Catalyst ·

2022/09/14

Join us as we discuss the latest developments in RCC coming out of ESMO22. In this episode, we recap the impact of 3 failed checkpoint-based regimen trials within the (neo)adjuvant setting and the first positive triplet data for advanced RCC.

en-us

00:14:59

Live From the Congress floor, ESMO 2022: NSCLC

Axiom Catalyst ·

2022/09/13

Join us as Rohan and Andrew discuss key takeaways from an impactful ESMO22 in NSCLC. In this episode, we recap the first Phase III data for a KRASG12C inhibitor, long-term follow-up from checkpoint-based regimens, and the first ADC approval in lung.

en-us

00:28:52

Live From the Congress floor, ESMO 2022: Dr. Hope Rugo

Axiom Catalyst ·

2022/09/12

Dr. Hope Rugo, University of California at San Francisco, joins Hafiz Sikder for an engaging discussion on the world of Breast Cancer. The discussion ranges from key ESMO data, the future of care, and healthcare disparities.

en-us

00:22:13

Pre-ESMO Curtain Raiser

Axiom Catalyst ·

2022/08/29

Join in this week as we review key data-set from ESMO as well as a deep dive into RCC, lung and pan-tumor discussions. Join in the discussion with your POV, comments, and questions.

en-us

00:21:09

Gustave Roussy

Axiom Catalyst ·

2022/07/14

Axiom Catalyst is live from Gustave Roussy! Hafiz Sikder joins Dr. Barlesi and the leading cancer treatment team in Villejuif, France for a discussion on the future of oncology.

en-us

00:09:43

ASCO Snacks, Day 2

Axiom Catalyst ·

2022/06/06

Live from the congress floor! Join Mahim Misra and Maressa Cumbermack for part 2 of our ASCO Snacks series, a quick download on the day’s most exciting events. Axiom Catalyst will record live at the 2022 American Society of Clinical Oncology’s Annual Meeting in Chicago.

en-us

00:13:59

ASCO Snacks, Day 1

Axiom Catalyst ·

2022/06/05

Live from the congress floor! Join Mahim Misra, Charlotte Caine, and Maressa Cumbermack for part 1 of our ASCO Snacks series, a quick download on the day’s most exciting events. Axiom Catalyst will record live at the 2022 American Society of Clinical Oncology’s Annual Meeting in Chicago.

en-us

00:20:32

Cell and Gene Therapy Discussions

Axiom Catalyst ·

2022/05/27

Vicky Kuo, MS, and Rohan Gidvani, PhD, join Hafiz and Mahim this week to discuss cell and gene therapy before ASCO 2022. Tune in for insights on challenges and emerging technologies from the Axiom Table.

en-us

00:20:56

Discussions in Lung Cancer with Dr. Hossein Borghaei

Axiom Catalyst ·

2022/05/13

Dr. Hossein Borghaei, Fox Chase Cancer Center, joins Hafiz and Mahim today to discuss updates in TIGIT, Immunotherapy, and more.

en-us

00:16:36

ASCO 2022 Curtain Raiser

Axiom Catalyst ·

2022/04/30

On Wednesday April 27, ASCO released 2800+ abstract titles spanning all major tumor types. On today’s podcast, we will give you a glimpse into some of the impactful abstracts that will be presented at ASCO in June. Topics will range from practice changing Phase III results from ADCs to emerging modalities like CAR-engineered allogeneic γδ T cells.

en-us

00:01:12

Axiom Catalyst Trailer

Axiom Catalyst ·

2022/04/25

Subscribe to the Axiom Catalyst! We will meet weekly to give you timely, holistic updates in life sciences.

en-us

40 results

Similar Podcasts

Classic Radio Science Fiction

solgoodmedia.com

Mission to Mars

Inception Point Ai

The 365 Days of Astronomy

365DaysOfAstronomy.org

Creek Devil

william Jevning

UFO Chronicles Podcast

Nik Hunter